
Algistor produces industrial-scale sterile algae and bacteria cultures to extract oleic fatty oils for industrial and commercial use. The company uses controlled sterile fermentation and downstream separation processes focused on microalgae such as Chlorella vulgaris, with artificial intelligence applied to optimize cultivation and extraction parameters. Algistor operates as a B2B biotech/manufacturing provider supplying algal oils and biomass to food, feed, and specialty-chemicals customers. Its offering combines sterile industrial cultivation, AI-driven process control, and lipid separation to scale production of specific fatty oils.

Algistor produces industrial-scale sterile algae and bacteria cultures to extract oleic fatty oils for industrial and commercial use. The company uses controlled sterile fermentation and downstream separation processes focused on microalgae such as Chlorella vulgaris, with artificial intelligence applied to optimize cultivation and extraction parameters. Algistor operates as a B2B biotech/manufacturing provider supplying algal oils and biomass to food, feed, and specialty-chemicals customers. Its offering combines sterile industrial cultivation, AI-driven process control, and lipid separation to scale production of specific fatty oils.
What they do: Industrial-scale sterile cultivation of algae and bacteria to produce algal oils and biomass for B2B customers
Tech focus: Sterile fermentation, downstream lipid separation, and AI-driven process optimization
HQ: Columbia, United States
Founded: 2022
Known funding: $50,000 grant from South Carolina Research Authority (Feb 2023)
Bio-manufacturing and sustainable ingredient production (algal oils, biomass) with greenhouse-gas capture co-benefits.
2022
Agriculture and Farming
$50,000